James Gajewski
About
James Gajewski is a scholar working on Hematology, Oncology and Immunology.
According to data from OpenAlex, James Gajewski has authored 131 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hematology, 37 papers in Oncology and 28 papers in Immunology. Recurrent topics in James Gajewski's work include Hematopoietic Stem Cell Transplantation (85 papers), Acute Myeloid Leukemia Research (30 papers) and Acute Lymphoblastic Leukemia research (24 papers). James Gajewski is often cited by papers focused on Hematopoietic Stem Cell Transplantation (85 papers), Acute Myeloid Leukemia Research (30 papers) and Acute Lymphoblastic Leukemia research (24 papers). James Gajewski collaborates with scholars based in United States, United Kingdom and Canada. James Gajewski's co-authors include Richard E. Champlin, Sergio Giralt, Issa F. Khouri, Börje S. Andersson, Paolo Anderlini, Donna Przepiorka, David F. Claxton, Naoto T. Ueno, Michèle L. Donato and Koen van Besien and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.
In The Last Decade
James Gajewski
130 papers receiving 9.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| James Gajewski United States | 48 | 7.8k | 3.2k | 2.8k | 2.1k | 1.6k | 131 | 9.9k | ||
| Thomas R. Chauncey United States | 50 | 7.8k 1.0× | 2.7k 0.8× | 2.7k 0.9× | 1.7k 0.8× | 2.2k 1.4× | 167 | 9.6k | ||
| Paolo Anderlini United States | 49 | 7.5k 1.0× | 3.1k 1.0× | 3.4k 1.2× | 1.6k 0.8× | 2.1k 1.3× | 210 | 10.3k | ||
| FR Appelbaum United States | 63 | 9.3k 1.2× | 3.4k 1.1× | 3.4k 1.2× | 2.0k 1.0× | 2.0k 1.3× | 189 | 12.4k | ||
| Haesook T. Kim United States | 52 | 6.6k 0.8× | 4.5k 1.4× | 2.2k 0.8× | 1.3k 0.7× | 1.9k 1.2× | 206 | 10.1k | ||
| F R Appelbaum United States | 47 | 6.0k 0.8× | 1.9k 0.6× | 2.9k 1.0× | 1.3k 0.6× | 1.2k 0.8× | 99 | 8.5k | ||
| K Doney United States | 55 | 8.7k 1.1× | 2.9k 0.9× | 2.6k 0.9× | 2.3k 1.1× | 1.7k 1.1× | 142 | 10.6k | ||
| Leo F. Verdonck Netherlands | 50 | 6.3k 0.8× | 2.6k 0.8× | 3.1k 1.1× | 1.7k 0.8× | 1.5k 1.0× | 158 | 9.9k | ||
| Karen K. Ballen United States | 45 | 5.8k 0.7× | 1.9k 0.6× | 2.1k 0.7× | 1.8k 0.9× | 1.9k 1.2× | 234 | 8.1k | ||
| Robert P. Witherspoon United States | 48 | 5.7k 0.7× | 2.3k 0.7× | 2.1k 0.7× | 1.2k 0.6× | 1.2k 0.8× | 104 | 8.0k | ||
| Linda J. Burns United States | 46 | 3.8k 0.5× | 2.8k 0.9× | 3.2k 1.1× | 1.2k 0.6× | 1.0k 0.7× | 197 | 7.7k |
Countries citing papers authored by James Gajewski
Since
Specialization
Citations
This map shows the geographic impact of James Gajewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Gajewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Gajewski more than expected).
Fields of papers citing papers by James Gajewski
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by James Gajewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Gajewski. The network helps show where James Gajewski may publish in the future.
Co-authorship network of co-authors of James Gajewski
This figure shows the co-authorship network connecting the top 25 collaborators of James Gajewski. A scholar is included among the top collaborators of James Gajewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Gajewski. James Gajewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Gajewski, James. (2020). Hematopoietic Stem Cell Transplantation, Where Have We Come and Where Do We Go. PubMed. 3(2). 37–43.
2.
Gajewski, James, Mark McClellan, Navneet S. Majhail, et al.. (2017). Payment and Care for Hematopoietic Cell Transplantation Patients: Toward a Specialized Medical Home for Complex Care Patients. Biology of Blood and Marrow Transplantation. 24(1). 4–12.
3.
Burns, Linda J., James Gajewski, Navneet S. Majhail, et al.. (2014). Challenges and Potential Solutions for Recruitment and Retention of Hematopoietic Cell Transplantation Physicians: The National Marrow Donor Program’s System Capacity Initiative Physician Workforce Group Report. Biology of Blood and Marrow Transplantation. 20(5). 617–621.
4.
Hahn, Theresa, Philip L. McCarthy, Anna Hassebroek, et al.. (2013). Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors. Journal of Clinical Oncology. 31(19). 2437–2449.
5.
Valcárcel, David, Jorge Sierra, Tao Wang, et al.. (2010). One-Antigen Mismatched Related versus HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Adults with Acute Leukemia: Center for International Blood and Marrow Transplant Research Results in the Era of Molecular HLA Typing. Biology of Blood and Marrow Transplantation. 17(5). 640–648.
6.
Murphy, Elizabeth, et al.. (2009). The National Marrow Donor Program's Symposium on Patient Advocacy in Cellular Transplantation Therapy: Addressing Barriers to Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 16(2). 147–156.
7.
Gajewski, James, C. Frederick LeMaistre, Samuel Silver, et al.. (2009). Impending Challenges in the Hematopoietic Stem Cell Transplantation Physician Workforce. Biology of Blood and Marrow Transplantation. 15(12). 1493–1501.
8.
Hanrahan, Emer O., Kristine Broglio, Aman U. Buzdar, et al.. (2006). Randomized trial of high‐dose chemotherapy and autologous hematopoietic stem cell support for high‐risk primary breast carcinoma. Cancer. 106(11). 2327–2336.
9.
Cheng, Yee Chung, Gabriela Rondón, Ying Yang, et al.. (2004). The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy. Biology of Blood and Marrow Transplantation. 10(11). 794–804.
10.
Rodriguez, Maria Alma, Koen van Besien, Fredrick B. Hagemeister, et al.. (2003). Randomized comparison of frontline alternating chemotherapy versus brief induction followed by autologous stem cell transplant for aggressive lymphomas. Blood. 102(11). 40216.
11.
Champlin, Richard E., Issa F. Khouri, Paolo Anderlini, et al.. (2001). Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Bone Marrow Transplantation. 27(S2). S13–S22.
12.
Gajewski, James, Michèle L. Donato, Sergio Giralt, et al.. (2000). Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy). Bone Marrow Transplantation. 25(S2). S35–S38.
13.
Thomas, Deborah A., Hagop M. Kantarjian, Terry L. Smith, et al.. (1999). Primary refractory and relapsed adult acute lymphoblastic leukemia. Cancer. 86(7). 1216–1230.
14.
Rowlings, Philip A., Julie M. Vose, Jamés O. Armitage, et al.. (1999). Autotransplants for Hodgkin's Disease in Patients Never Achieving Remission: A Report From the Autologous Blood and Marrow Transplant Registry. Journal of Clinical Oncology. 17(2). 534–534.
15.
Choudhury, Aniruddha, James Gajewski, Jan C. Liang, et al.. (1997). Use of Leukemic Dendritic Cells for the Generation of Antileukemic Cellular Cytotoxicity Against Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia. Blood. 89(4). 1133–1142.
16.
Besien, Koen van, Rakesh Mehra, Sergio Giralt, et al.. (1996). Allogeneic bone marrow transplantation for poor-prognosis lymphoma: Response, toxicity, and survival depend on disease histology. The American Journal of Medicine. 100(3). 299–307.
17.
Besien, Koen van, Donna Przepiorka, Rakesh Mehra, et al.. (1996). Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies.. Journal of Clinical Oncology. 14(11). 3036–3042.
18.
Chan, Ka Wah, et al.. (1996). Use of minors as bone marrow donors: Current attitude and management. The Journal of Pediatrics. 128(5). 644–648.
19.
Schiller, Gary J., S D Nimer, Mary Territo, et al.. (1992). Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission.. Journal of Clinical Oncology. 10(1). 41–46.
20.
Champlin, Richard E., J Jansen, W. G. Ho, et al.. (1991). Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.. PubMed. 23(1 Pt 2). 1695–6.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Thomas R. Chauncey Breakdown of academic impact, for papers by Paolo Anderlini Breakdown of academic impact, for papers by FR Appelbaum Breakdown of academic impact, for papers by Haesook T. Kim Breakdown of academic impact, for papers by F R Appelbaum Breakdown of academic impact, for papers by K Doney Breakdown of academic impact, for papers by Leo F. Verdonck Breakdown of academic impact, for papers by Karen K. Ballen Breakdown of academic impact, for papers by Robert P. Witherspoon Breakdown of academic impact, for papers by Linda J. Burns